Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 156-162

  Deenadayalan, Anbarasu ^a   Sundaramurthi, Jagadish Chandrabose ^a   Raja, Alamelu ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Culture filtrate proteins; Isoelectric focusing; Mass spectrometry; Rotofor; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MYCOBACTERIUM ANTIGEN; PROTEIN ACPM; PROTEIN DERIVATIVE; PROTEIN PPIA; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL PROCEDURES; ISOELECTRIC FOCUSING; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEOMICS; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHEMICAL FRACTIONATION; CULTURE MEDIA; FEMALE; HUMANS; INTERFERON-GAMMA; ISOELECTRIC FOCUSING; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TUBERCULIN; TUBERCULIN TEST;

MYCOBACTERIUM TUBERCULOSIS;

EID: 74749096993     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.11.008     Document Type: Article

References (36)

1. Andersen P., and Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3 8 (2005) 656-662
2. Baily G.V. Tuberculosis prevention trial, Madras. Indian. J Med. Res. 72 Suppl (1980) 1-74
3. Bhaskar S., Khanna S.P., and Mukherjee R. Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis. Vaccine 18 25 (2000) 2856-2866
4. Bui H.H., Sidney J., Dinh K., Southwood S., Newman M.J., and Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7 (2006) 153
5. Covert B.A., Spencer J.S., Orme I.M., and Belisle J.T. The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics 1 4 (2001) 574-586
6. de Souza G.A., Malen H., Softeland T., Saelensminde G., Prasad S., Jonassen I., and Wiker H.G. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 9 (2008) 316
7. Diaz F., Masso F., Paez A., Varela E., Suarez-Guemes F., and Montano L.F. Secretion of IFN-gamma by bovine peripheral blood mononuclear cells stimulated with Mycobacterium bovis protein fractions obtained by isoelectric-focusing. Vet. Immunol. Immunopathol. 67 3 (1999) 203-212
8. Diaz-Quinonez A., Martin-Orozco N., Isibasi A., and Ortiz-Navarrete V. Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition. Infect. Immun. 72 5 (2004) 3059-3062
9. Doherty T.M., Demissie A., Olobo J., Wolday D., Britton S., Eguale T., Ravn P., and Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40 2 (2002) 704-706
10. Fine P.E. Bacille Calmette-Guerin vaccines: a rough guide. Clin. Infect. Dis. 20 1 (1995) 11-14
11. Floto R.A., MacAry P.A., Boname J.M., Mien T.S., Kampmann B., Hair J.R., Huey O.S., Houben E.N., Pieters J., Day C., Oehlmann W., Singh M., Smith K.G., and Lehner P.J. Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 314 5798 (2006) 454-458
12. Fonseca D.P., Benaissa-Trouw B., van Engelen M., Kraaijeveld C.A., Snippe H., and Verheul A.F. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Infect. Immun. 69 8 (2001) 4839-4845
13. Geluk A., Lin M.Y., van Meijgaarden K.E., Leyten E.M., Franken K.L., Ottenhoff T.H., and Klein M.R. T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect. Immun. 75 6 (2007) 2914-2921
14. Gomez M., Johnson S., and Gennaro M.L. Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect. Immun. 68 4 (2000) 2323-2327
15. Gopi P.G., Subramani R., Nataraj T., and Narayanan P.R. Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India. Indian J. Med. Res. 124 1 (2006) 71-76
16. Hill P.C., Jackson-Sillah D., Fox A., Franken K.L., Lugos M.D., Jeffries D.J., Donkor S.A., Hammond A.S., Adegbola R.A., Ottenhoff T.H., Klein M.R., and Brookes R.H. ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia. J. Clin. Microbiol. 43 5 (2005) 2070-2074
17. Kumar P., Amara R.R., Challu V.K., Chadda V.K., and Satchidanandam V. The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect. Immun. 71 4 (2003) 1929-1937
18. Lim J.H., Kim H.J., Lee K.S., Jo E.K., Song C.H., Jung S.B., Kim S.Y., Lee J.S., Paik T.H., and Park J.K. Identification of the new T-cell-stimulating antigens from Mycobacterium tuberculosis culture filtrate. FEMS Microbiol. Lett. 232 1 (2004) 51-59
19. Malen H., Berven F.S., Fladmark K.E., and Wiker H.G. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7 10 (2007) 1702-1718
20. Mustafa A.S., and Shaban F.A. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 86 2 (2006) 115-124
21. Nicod L.P. Immunology of tuberculosis. Swiss Med. Wkly. 137 25-26 (2007) 357-362
22. Qamra R., Mande S.C., Coates A.R., and Henderson B. The unusual chaperonins of Mycobacterium tuberculosis. Tuberculosis (Edinb) 85 5-6 (2005) 385-394
23. Righetti P.G., Castagna A., Antonioli P., and Boschetti E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 26 2 (2005) 297-319
24. Sable S.B., Kumar R., Kalra M., Verma I., Khuller G.K., Dobos K., and Belisle J.T. Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infect. Immun. 73 6 (2005) 3547-3558
25. Selvakumar N., Murthy B.N., Prabhakaran E., Sivagamasundari S., Vasanthan S., Perumal M., Govindaraju R., Chauhan L.S., Wares F., Santha T., and Narayanan P.R. Lot quality assurance sampling of sputum acid-fast bacillus smears for assessing sputum smear microscopy centers. J. Clin. Microbiol. 43 2 (2005) 913-915
26. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 12 (2001) 1236-1237
27. Smith S.M., Malin A.S., Lukey P.T., Atkinson S.E., Content J., Huygen K., and Dockrell H.M. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect. Immun. 67 10 (1999) 5223-5230
28. Tam S. Electrophoretic prefractionation: new commercial tools from an old concept. Expert. Rev. Proteomics 3 4 (2006) 379-381
29. Tavares R.C., Salgado J., Moreira V.B., Ferreira M.A., Mello F.C., Leung J.A., Singh M., Fonseca Lde S., and Saad M.H. Cell proliferation and interferon-gamma response to recombinant MBP-3, NarL, MT-10.3, and 16 kDa Mycobacterium tuberculosis antigens in Brazilian tuberculosis patients. Mem. Inst. Oswaldo Cruz 101 8 (2006) 857-861
30. Trajkovic V., Singh G., Singh B., Singh S., and Sharma P. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide. Infect. Immun. 70 12 (2002) 6558-6566
31. Ulrichs T., Munk M.E., Mollenkopf H., Behr-Perst S., Colangeli R., Gennaro M.L., and Kaufmann S.H. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28 12 (1998) 3949-3958
32. Weir R.E., Morgan A.R., Britton W.J., Butlin C.R., and Dockrell H.M. Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J. Immunol. Methods 176 1 (1994) 93-101
33. Weldingh K., Rosenkrands I., Jacobsen S., Rasmussen P.B., Elhay M.J., and Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect. Immun. 66 8 (1998) 3492-3500
34. Weldingh K., Rosenkrands I., Okkels L.M., Doherty T.M., and Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J. Clin. Microbiol. 43 1 (2005) 57-65
35. WHO. World Health Organization, Global Tuberculosis Control-Surveillance, Planning, Financing (2008), WHO Report
36. Yew W.W., and Leung C.C. Update in tuberculosis 2007. Am. J. Respir. Crit. Care Med. 177 5 (2008) 479-485